Abrdn Life Sciences Investors (HQL)
NYSE: HQL · Real-Time Price · USD
20.96
-0.59 (-2.74%)
At close: Aug 28, 2026, 4:00 PM EDT
20.90
-0.06 (-0.29%)
After-hours: Aug 28, 2026, 7:00 PM EDT

HQL Ratios and Metrics

Millions USD. Fiscal year is Oct - Sep.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Market Capitalization
637448412327343505
Market Cap Growth
-8.58%26.18%-4.83%-31.99%22.27%
Enterprise Value
637448412336352505
Last Close Price
20.9613.7111.668.558.5511.91

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
PE Ratio
3.225.234.8414.62-7.83
PS Ratio
574.32231.02103.6393.42113.77220.89
PB Ratio
1.140.870.900.810.860.97
P/TBV Ratio
1.140.870.900.810.860.97
P/OCF Ratio
16.0114.12----

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
EV/Sales Ratio
573.55231.02103.6396.09116.55220.89

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Debt / Equity Ratio
----0.030.02
Net Debt / Equity Ratio
-0000.030.02
Asset Turnover
0.000.000.010.010.010.00
Quick Ratio
1.550.710.277.570.040.01
Current Ratio
1.610.730.3230.460.700.80
Return on Equity (ROE)
41.42%17.59%19.80%5.59%-22.71%12.82%
Return on Assets (ROA)
-0.61%-0.43%-0.28%-0.33%-0.39%-0.51%
Return on Capital Employed (ROCE)
-0.80%-0.70%-0.40%-0.50%-0.80%-0.80%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Earnings Yield
31.09%19.11%20.68%6.84%-30.45%12.78%
Dividend Yield
8.68%13.27%14.24%14.96%17.19%14.02%
Payout Ratio
34.37%36.96%----
Buyback Yield / Dilution
-5.32%-5.48%-4.74%-4.33%-4.10%-3.29%
Total Shareholder Return
3.36%7.79%9.50%10.63%13.09%10.73%
SEC Filings: 10-K · 10-Q